TY - JOUR
KW - Adolescent
KW - Age Factors
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine, Naloxone Drug Combination/therapeutic use
KW - Cognitive Therapy
KW - Combined Modality Therapy
KW - Craving/drug effects
KW - Drug Therapy, Combination
KW - Female
KW - Heroin Dependence/rehabilitation
KW - Humans
KW - Male
KW - Memantine/therapeutic use
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/rehabilitation
KW - Psychotherapy, Group
KW - Substance Withdrawal Syndrome/etiology
KW - Substance-Related Disorders/rehabilitation
KW - Young Adult
KW - buprenorphine
KW - Heroin
KW - Young adults
AU - Mauricio Romero-Gonzalez
AU - Abtin Shahanaghi
AU - Gregory J. DiGirolamo
AU - Gerardo Gonzalez
A1 - 
AD - Division of Addiction Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts.; MAYU of New England, New Haven, Connecticut.; Division of Addiction Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts.; Department of Psychiatry, Boston University, Boston, Massachusetts.; Division of Addiction Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts.; College of the Holy Cross, Worcester, Massachusetts.; Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts.; Division of Addiction Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts.; MAYU of New England, New Haven, Connecticut.; VA Central Western Massachusetts Healthcare System, Leeds, Massachusetts.
BT - The American journal on addictions
C5 - Measures; Opioids & Substance Use
CP - 8
CY - England
DO - 10.1111/ajad.12641
IS - 8
JF - The American journal on addictions
LA - eng
M1 - Journal Article
PB - American Academy of Addiction Psychiatry
PP - England
PY - 2017
SN - 1521-0391; 1055-0496
SP - 838
EP - 844
EP - 
T1 - Buprenorphine-naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders
T2 - The American journal on addictions
TI - Buprenorphine-naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders
U1 - Measures; Opioids & Substance Use
U2 - 29143399
U3 - 10.1111/ajad.12641
VL - 26
VO - 1521-0391; 1055-0496
Y1 - 2017
Y2 - Dec
ER -